Biopelta, UAB - financials and debts

Company age: 10 y. 9 mo.

Update

Biopelta - Company finances

EUR
2018
From: 2018-01-01
To: 2018-12-31
2019
From: 2019-01-01
To: 2019-12-31
2020
From: 2020-01-01
To: 2020-12-31
2021
From: 2021-01-01
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 3,850 133,647 138,799 215,610 149,738 236,837 136,393 171,303
Profit before tax 3,551 5,969 5,264 7,352 1,127 1,524 6,549 1,150
Net profit 3,394 5,057 4,474 6,984 1,071 1,295 6,222 1,081
Equity 9,744 14,801 19,193 26,163 27,235 28,530 34,752 30,582
Liabilities 1,079 29,264 16,598 51,088 63,024 64,382 64,098 137,346
Non-current assets 0 8,358 7,263 32,167 33,510 53,689 37,947 64,699
Current assets 10,823 35,707 28,528 45,084 56,749 39,223 60,903 103,229
Total assets 10,823 44,065 35,791 77,251 90,259 92,912 98,850 167,928
Taxes paid
STI taxes - - - - - - 263 6,438
Social insurance contributions - - - - - 8,563 13,649 15,075
Financial indicators
Revenue change y/y -65.2% +3371.4% +3.9% +55.3% -30.6% +58.2% -42.4% +25.6%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 31.4% 11.5% 12.5% 9.0% 1.2% 1.4% 6.3% 0.6%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. 34.8% 34.2% 23.3% 26.7% 3.9% 4.5% 17.9% 3.5%
Profit margin Net profit margin. Shows the overall profitability of the company. 88.2% 3.8% 3.2% 3.2% 0.7% 0.5% 4.6% 0.6%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. 92.2% 4.5% 3.8% 3.4% 0.8% 0.6% 4.8% 0.7%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. 0.1 2.0 0.9 2.0 2.3 2.3 1.8 4.5
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. 3,850 36,121 50,472 47,043 32,670 48,170 29,227 41,952

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Biopelta - Social security debts

From To Debt, €
2026-08-26 2026-09-02 2526.67
2026-08-23 2026-08-23 2526.67
2026-08-19 2026-08-19 2526.67
2026-05-03 2026-05-14 34.94
2026-04-28 2026-04-29 34.94
2026-04-23 2026-04-26 34.94
2026-03-29 2026-04-01 1922.06
2026-03-15 2026-03-27 1922.06
2026-02-18 2026-03-11 1922.06
2026-01-21 2026-02-17 1561.65
2026-01-16 2026-01-20 1539.32
2026-01-01 2026-01-15 1019.39
2025-12-16 2025-12-30 1073.77
2025-12-02 2025-12-08 1464.66
2025-11-18 2025-12-01 1464.89
2025-10-30 2025-11-17 5.58
2025-10-27 2025-10-29 1263.36
2025-10-26 2025-10-26 1459.31
2025-10-23 2025-10-25 1464.89
2025-10-16 2025-10-22 1459.31
2025-08-31 2025-09-03 243.46
2025-08-25 2025-08-27 243.46
2025-07-30 2025-08-13 8.96
2025-07-28 2025-07-29 792.47
2025-07-26 2025-07-27 783.51
2025-07-25 2025-07-25 792.47
2025-07-24 2025-07-24 920.44
2025-07-16 2025-07-23 1329.59
2025-06-17 2025-06-19 1129.89
2025-05-16 2025-05-19 1426.90
2025-05-04 2025-05-15 1.89
2025-04-30 2025-04-30 1448.01
2025-04-28 2025-04-29 1375.11
2025-04-24 2025-04-27 1449.90
2025-04-16 2025-04-23 1448.01
2025-03-18 2025-03-20 1418.35
2025-01-22 2025-02-13 1.45
2024-11-18 2024-12-12 0.48
2024-10-16 2024-10-22 1085.91
2024-06-18 2024-06-20 1221.69
2024-05-16 2024-05-19 1292.97
2024-04-16 2024-04-18 489.30
2023-09-18 2023-09-18 891.15
2023-06-16 2023-06-18 1446.33
2023-02-17 2023-02-20 45.96
2023-01-17 2023-01-17 19.11
2022-04-21 2022-04-21 785.44
2022-04-19 2022-04-20 825.44

Biopelta - VMI tax arrears

As of 2026-09-02, the amount of overdue STI tax debt of the company Biopelta is: 1,688 €

From To Overdue, €
2026-09-02 2026-09-02 1687.97
2026-08-31 2026-09-01 1686.62
2026-08-30 2026-08-30 1686.17
2026-08-28 2026-08-29 1685.26
2026-08-26 2026-08-27 1644.82
2026-08-25 2026-08-25 1644.38
2026-08-18 2026-08-24 1641.3
2026-08-14 2026-08-17 1630.64
2026-08-13 2026-08-13 57.4
2026-05-26 2026-05-26 195.55
2026-05-25 2026-05-25 195.4
2026-05-22 2026-05-24 195.35
2026-05-20 2026-05-21 195.25
2026-05-15 2026-05-19 175.91
2026-01-23 2026-01-23 514.63
2026-01-22 2026-01-22 514.5
2026-01-20 2026-01-21 514.24
2026-01-19 2026-01-19 513.98
2026-01-18 2026-01-18 511.77
2026-01-16 2026-01-17 510.81
2025-12-24 2025-12-29 7.7
2025-12-23 2025-12-23 844.93
2025-12-22 2025-12-22 844.27
2025-12-19 2025-12-21 844.05
2025-12-18 2025-12-18 843.61
2025-12-17 2025-12-17 844.11
2025-11-15 2025-11-25 968.25
2025-11-06 2025-11-14 1.67
2025-11-02 2025-11-05 498.26
2025-10-30 2025-11-01 1235.8
2025-10-23 2025-10-29 11.16
2025-10-22 2025-10-22 10.85
2025-10-21 2025-10-21 1185.8
2025-10-19 2025-10-20 1184.87
2025-10-02 2025-10-18 0.18
2025-09-25 2025-09-26 242.81
2025-09-22 2025-09-24 242.69
2025-09-20 2025-09-21 245.97
2025-09-19 2025-09-19 1100.97
2025-09-17 2025-09-18 1093.29
2025-07-17 2025-07-25 0.02
2025-07-16 2025-07-16 89.9
2025-04-25 2025-04-25 1.89
2025-04-24 2025-04-24 1012.07
2025-04-23 2025-04-23 1011.8
2025-04-18 2025-04-22 1010.45
2025-04-17 2025-04-17 1010.18
2025-04-16 2025-04-16 1002.43
2025-04-10 2025-04-15 440.7
2025-04-09 2025-04-09 440.58
2025-04-03 2025-04-08 553.89
2025-04-02 2025-04-02 553.46
2025-03-28 2025-04-01 1052.34
2024-11-21 2024-11-25 0.15
2024-11-20 2024-11-20 574.26
2024-11-17 2024-11-19 569.05

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Biopelta, UAB (code 304145918) is a Private Limited Liability Company engaged in construction of utility projects for fluids. In 2025, the company generated revenue of EUR 171.3K, up 25.6% year on year, after EUR 136.4K in 2024 and EUR 236.8K in 2023. Despite the recent revenue recovery, profitability remained modest: net profit in 2025 was EUR 1.1K, compared with EUR 6.2K in 2024 and EUR 1.3K in 2023, resulting in a 0.6% net margin. Balance sheet size expanded to EUR 167.9K in 2025 from EUR 98.8K in 2024 and EUR 92.9K in 2023, supported by stronger short-term assets of EUR 103.2K and long-term assets of EUR 64.7K. Equity stood at EUR 30.6K, while liabilities increased to EUR 137.3K, leaving an equity ratio of 18.2% and a debt-to-equity ratio of 4.49. Reported efficiency indicators for 2025 were ROE of 3.5%, ROA of 0.6%, and asset turnover of 1.02x. Revenue per employee was EUR 42.8K, while profit per employee was EUR 270.